Chemistry: molecular biology and microbiology – Micro-organism – per se ; compositions thereof; proces of...
Patent
1999-06-11
2000-11-14
Sisson, Bradley L.
Chemistry: molecular biology and microbiology
Micro-organism, per se ; compositions thereof; proces of...
4352523, 4353201, 536 232, 536 235, 536 2431, C12N 120, C12N 1500, C07H 2104
Patent
active
061468762
ABSTRACT:
The present invention relates to a newly identified human cyclic nucleotide phosphodiesterase belonging to the superfamily of mammalian phosphodiesterases. The invention also relates to polynucleotides encoding the phosphodiesterase. The invention further relates to methods using the phosphodiesterase polypeptides and polynucleotides as a target for diagnosis and treatment in phosphodiesterase-mediated or -related disorders. The invention further relates to drug-screening methods using the phosphodiesterase polypeptides and polynucleotides to identify agonists and antagonists for diagnosis and treatment. The invention further encompasses agonists and antagonists based on the phosphodiesterase polypeptides and polynucleotides. The invention further relates to procedures for producing the phosphodiesterase polypeptides and polynucleotides.
REFERENCES:
patent: 5527896 (1996-06-01), Wigler et al.
patent: 5702936 (1997-12-01), Beavo et al.
patent: 5798246 (1998-08-01), Au-Young et al.
patent: 5851784 (1998-12-01), Owens et al.
Michaeli, Tamar, et al., "Isolation and Characterization of a Previously Undetected Human cAMP Phosphodiesterase by Complementation of cAMP Phosphodiesterase-deficient Saccharomyces cervisiae," The Journal Of Biological Chemistry, vol. 268, No. 17, pp. 12, Jun. 1993.
Bloom, T., et al., "Identification and tissue-specific expression of PDE7 phosphodiesterase splice variants," Proceedings of the National Academy of Sciences, USA, vol. 93, pp. 14188-14192, Nov. 1996.
ID CN7A.sub.-- HUMAN, Jun. 1993.
ID CN7A.sub.-- MOUSE, Nov. 1996.
Houslay et al. (1997), "Tailoring cAMP-Signalling Responses Through Isoform Multiplicity", TiBS 22:217:224.
Bloom et al. (1996), "Identification and Tissue-Specific Expression of PDE7 Phosphodiesterase Splice Variants", Proc. Natl. Acad. Sci. USA 93:14188-14192.
Han et al. (1997), "Alternative Splicing of the High Affinity cAMP-Specific Phosphodiesterase (PDE7A) mRNA in Human Skeletal Muscle and Heart", The Journal of Biological Chemistry 272 (26):16152-16157.
Beavo (1995), "Cyclic Nucleotide Phosphodiesterases: Functional Implications of Multiple Isoforms", Physiological Reviews 75(4):725-748.
DNA Blast Analysis Against NUC, PrevPatent Databases.
Protein Blast Analysis Against PNU, Patent Databases.
Kapeller-Libermann Rosana
Robision Keith E.
White David
Millennium Pharmaceuticals Inc.
Sisson Bradley L.
LandOfFree
22025, a novel human cyclic nucleotide phosphodiesterase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 22025, a novel human cyclic nucleotide phosphodiesterase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 22025, a novel human cyclic nucleotide phosphodiesterase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2063929